Correlation Between Crispr Therapeutics and PTC Therapeutics
Can any of the company-specific risk be diversified away by investing in both Crispr Therapeutics and PTC Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crispr Therapeutics and PTC Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crispr Therapeutics AG and PTC Therapeutics, you can compare the effects of market volatilities on Crispr Therapeutics and PTC Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crispr Therapeutics with a short position of PTC Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crispr Therapeutics and PTC Therapeutics.
Diversification Opportunities for Crispr Therapeutics and PTC Therapeutics
0.15 | Correlation Coefficient |
Average diversification
The 3 months correlation between Crispr and PTC is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Crispr Therapeutics AG and PTC Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PTC Therapeutics and Crispr Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crispr Therapeutics AG are associated (or correlated) with PTC Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PTC Therapeutics has no effect on the direction of Crispr Therapeutics i.e., Crispr Therapeutics and PTC Therapeutics go up and down completely randomly.
Pair Corralation between Crispr Therapeutics and PTC Therapeutics
Given the investment horizon of 90 days Crispr Therapeutics AG is expected to generate 1.38 times more return on investment than PTC Therapeutics. However, Crispr Therapeutics is 1.38 times more volatile than PTC Therapeutics. It trades about 0.1 of its potential returns per unit of risk. PTC Therapeutics is currently generating about 0.01 per unit of risk. If you would invest 3,936 in Crispr Therapeutics AG on November 1, 2024 and sell it today you would earn a total of 185.00 from holding Crispr Therapeutics AG or generate 4.7% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Crispr Therapeutics AG vs. PTC Therapeutics
Performance |
| Timeline |
| Crispr Therapeutics |
| PTC Therapeutics |
Crispr Therapeutics and PTC Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Crispr Therapeutics and PTC Therapeutics
The main advantage of trading using opposite Crispr Therapeutics and PTC Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crispr Therapeutics position performs unexpectedly, PTC Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PTC Therapeutics will offset losses from the drop in PTC Therapeutics' long position.| Crispr Therapeutics vs. Beam Therapeutics | Crispr Therapeutics vs. Editas Medicine | Crispr Therapeutics vs. Caribou Biosciences | Crispr Therapeutics vs. Verve Therapeutics |
| PTC Therapeutics vs. Surrozen | PTC Therapeutics vs. Armata Pharmaceuticals | PTC Therapeutics vs. Pasithea Therapeutics Corp | PTC Therapeutics vs. Aditxt Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |